Palisade Bio (PALI) Stock Price, Quote, News & History

Q: What sector and industry does Palisade Bio (PALI) operate in?

Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Palisade Bio Inc (PALI) Stock Price, Quote, News & History

PALINASDAQ

Trade with Public

$1.72

At close: Feb 10, 4:00 PM EST

$1.70

-0.0181-1.05%

After Hours: 7:45 PM EST

Overview

News Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 5.12M

Day Range

- - -

52 Wk Range

0.53 - 2.64

Market Cap

$253.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

11.74%

Days to Cover

3.02

Recent Palisade Bio Inc News

Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December

Avi Kapoor

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.08M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

7.27M

Free Cash Flow (TTM)

-10.08M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-2.81M

Analyst Trends and Forecast

2

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$239.68M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

80.41

Earnings Yield % (TTM)

-119.65%

Earnings Yield % (FWD)

-7.23%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

$211.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.23M

Debt to Equity

0.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$336.00K

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 5.12M

Day Range

- - -

52 Wk Range

0.53 - 2.64

Market Cap

$253.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

11.74%

Days to Cover

3.02

About

Sector

Health Care

Industry

Biotechnology

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Palisade Bio (PALI) stock?

A

You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Palisade Bio (PALI) competitors?

A

Other companies in Palisade Bio’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Larimar Therapeutics Inc (NASDAQ:LRMR), Armata Pharmaceuticals Inc (AMEX:ARMP), Enlivex Therapeutics Ltd (NASDAQ:ENLV) and Fennec Pharmaceuticals Inc (NASDAQ:FENC).

Q

What is the forecast, or price target, for Palisade Bio (PALI) stock?

A

Palisade Bio has a consensus price target of $14.00.

Q

What is the current price for Palisade Bio (PALI)?

A

The stock price for Palisade Bio (NASDAQ: PALI) is $1.7019 last updated February 9, 2026 at 7:45 PM EST.

Q

Does Palisade Bio (PALI) pay a dividend?

A

There are no upcoming dividends for Palisade Bio.

Q

When is Palisade Bio (NASDAQ:PALI) reporting earnings?

A

Palisade Bio does not have any upcoming earnings scheduled.

Q

Is Palisade Bio (PALI) going to split?

A

There is no upcoming split for Palisade Bio.

Q

What sector and industry does Palisade Bio (PALI) operate in?

A

Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Larimar Therapeutics Inc

NASDAQ:LRMR

$3.39

%

ARMP

Enlivex Therapeutics Ltd

NASDAQ:ENLV

$1.19

%

Silence Therapeutics PLC

NASDAQ:SLN

$4.75

%

Fennec Pharmaceuticals Inc

Abeona Therapeutics Inc

NASDAQ:ABEO

$5.14

%

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 5.12M

Day Range

- - -

52 Wk Range

0.53 - 2.64

Market Cap

$253.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

11.74%

Days to Cover

3.02

Recent Palisade Bio Inc News

Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December

Avi Kapoor

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.08M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

7.27M

Free Cash Flow (TTM)

-10.08M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-2.81M

Analyst Trends and Forecast

2

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$239.68M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

80.41

Earnings Yield % (TTM)

-119.65%

Earnings Yield % (FWD)

-7.23%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

$211.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.23M

Debt to Equity

0.07

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$336.00K

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 5.12M

Day Range

- - -

52 Wk Range

0.53 - 2.64

Market Cap

$253.93M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

11.74%

Days to Cover

3.02

About

Sector

Health Care

Industry

Biotechnology

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry